ArticleCell death and differentiation2020

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis.

Serena Mancarella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.